We provide a biomarker analysis service for MOA and POC confirmation. Moreover, the novel biomarker discovery service is also available for personalized therapy and companion diagnostics. The biomarker analysis and novel biomarker discovery service will facilitate progression to clinical trials and enhance the possibility of new drug development.
List of Models
- Various cancer cell lines, genetically manipulated cell line panel by biomarker, drug-resistant cell line
- Animal models with various cancer cell line implantations. genetically modified cell line and mouse model of genetic modification
- Patient-derived primary cells with clinical, gene, and drug reactivity data, patient-derived xenograft (PDX) model, and patient samples (cancer tissue, normal tissue, blood etc.)
- Toxicity evaluation model via biomarker
- New model establishment according to client inquiry
Service
- Customized test design (in vitro, in vivo, ex vivo)
- Biomarker verification and analysis based on therapeutic response
- Discovery of biomarker based on clinical needs
- Early diagnosis and prognosis prediction biomarker verification
- Application of clinical sample (blood, tissue) in customized cancer model
- Drug-associated diagnosis biomarker identification
- Next-generation sequencing-based Genomic alteration, Copy number variation, Expression level
- Protein modification based on Reverse phase protein array etc.
- MOA & POC verification
